-
JiAnTeBo and Sanyou Biopharmaceuticals Join Forces to Discover Metabolic Disease Targets and Develop Agonistic Antibodies
•
Guangdong JiAnTeBo Biotechnology Co., Ltd, a Chinese biotechnology company, has entered into a strategic partnership with Sanyou Biopharmaceuticals Co., Ltd. The collaboration aims to uncover new targets in metabolic diseases, including obesity, fatty liver, diabetes, and Alzheimer’s disease, with a focus on developing new pipelines of agonistic antibody drugs based…
